Related Experiment Video
Updated: Mar 28, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer
Background:
Triple-Negative Breast Cancer (TNBC) is an aggressive disease with a poor prognosis. Clinically, TNBC patients have limited treatment options besides chemotherapy. The goal of this study was to determine the kinase dependency in TNBC cell lines and to predict compounds that could inhibit these kinases using integrative bioinformatics analysis.
Results:
We integrated publicly available gene expression data, high-throughput pharmacological profiling data, and quantitative in vitro kinase binding data to determine the kinase dependency in 12 TNBC cell lines. We employed Kinase Addiction Ranker (KAR), a novel bioinformatics approach, which integrated these data sources to dissect kinase dependency in TNBC cell lines. We then used the kinase dependency predicted by KAR for each TNBC cell line to query K-Map for compounds targeting these kinases. We validated our predictions using published and new experimental data.
Conclusions:
In summary, we implemented an integrative bioinformatics analysis that determines kinase dependency in TNBC. Our analysis revealed candidate kinases as potential targets in TNBC for further pharmacological and biological studies.
Insights
Researchers identified key protein kinase targets in triple-negative breast cancer (TNBC) using a novel bioinformatics approach. This study predicts potential drug compounds to treat this aggressive cancer, offering new therapeutic avenues.
Area of Science:
- Oncology
- Bioinformatics
- Pharmacology
Background:
- Triple-Negative Breast Cancer (TNBC) is an aggressive subtype with limited therapeutic options beyond chemotherapy.
- Identifying specific molecular targets is crucial for developing effective TNBC treatments.
Purpose of the Study:
- To determine kinase dependency in TNBC cell lines.
- To predict potential inhibitory compounds for identified kinases using bioinformatics.
Main Methods:
- Integrated gene expression, pharmacological profiling, and kinase binding data.
- Employed a novel bioinformatics approach, Kinase Addiction Ranker (KAR).
- Queried K-Map to identify compounds targeting predicted kinases.
Main Results:
- Dissected kinase dependency across 12 TNBC cell lines.
- Identified candidate kinases as potential therapeutic targets.
- Validated predictions using existing and new experimental data.
Conclusions:
- An integrative bioinformatics analysis successfully determined kinase dependency in TNBC.
- Revealed candidate kinases for further investigation in TNBC treatment strategies.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...